Conference Day One

Download your copy of the full event guide for a comprehensive view of all 3 conference days.

7:15 am
Registration & Morning Coffee

8:00 am Chair’s Opening Remarks

Navigating the Future Outlook of Successful mRNA-Based Therapeutics & Vaccines

8:15 am Panel Discussion: With the Next Wave of mRNA on the Rise, What’s Next? The Biopharma Outlook

  • Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing, BioNTech
  • Danilo Casimiro Chief Science Officer & Global Head, External Scientific Affairs, Vaccines R&D, Sanofi
  • Gregory Fiore Co-Founder & Chief Executive Officer, Exacis Biotherapeutics
  • Steve Pascolo Researcher, University Hospital Zurich

Synopsis

For more information on this session, please download the full event guide.

8:45 am Building capacity for the Development & Production of mRNA Vaccines in Low & Middle Income Countries (LMICs)

  • Cristina Bruno Program Manager - mRNA Technology Transfer, World Health Organization

Synopsis

For more information on this session, please download the full event guide.

9:15 am Connecting the mRNA Production Process with Chromatography

  • Tomas Kostelec Technology and Business Development Manager, Sartorius BIA Separations

Synopsis

For more information on this session, please download the full event guide.

9:45 am
Morning Refreshment Break & Speed Networking

12:15 pm
Networking Lunch Break

3:10 pm
Afternoon Networking Break & Poster Session

3:40 pm Protein-Based Nanocapsules for Therapeutic RNA Delivery

  • Oliver Ernst Managing Director, Chief Executive Officer, NEUWAY Pharma

Synopsis

For more information on this session, please download the full event guide.

mRNA Progress Outside of Infectious Disease

4:10 pm Leveraging Targeted mRNA Therapeutics

Synopsis

For more information on this session, please download the full event guide.

4:40 pm Insights into our Fully Integrated CDMO Offering: From mRNA Manufacturing to LNP Formulation Development

  • Eleni Samaridou Principal Scientist, Early Formulation Screening Service, Life Science Services, Merck KGaA
  • Christof Trabszo Head of Quality Control, mRNA CDMO, Life Science Services, Merck KGaA

Synopsis

For more information on this session, please download the full event guide.

5:10 pm Presenting mRNA Therapeutics for the Treatment of Primary Ciliary Dyskinesia

Synopsis

For more information on this session, please download the full event guide.

5:40 pm Evaluating Vaccines & Therapies Based on mRNA

Synopsis

For more information on this session, please download the full event guide.

6:10 pm
Chair’s Closing Remarks & End of Conference Day 1